Cardiff Oncology, Inc. (CRDF) has a market capitalization of $116.22M and trades at $1.70. The 52-week range is 1.48-4.56.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.5, Earnings Per Share (EPS) of $-0.69, annual revenue of $593K.
The stock has a beta of 1.42, operates in the Healthcare sector.
